Who
Daniel N. Swisher Jr.
Director
Company insider
Files Form 4 as: Director, Corcept Therapeutics; Director, Cerus; Director, Protagonist Therapeutics; President and COO, Jazz Pharmaceuticals; President and CEO, Sunesis Pharmaceuticals.
In numbers
- Trades disclosed
- 265
- Buys
- 12
- Sells
- 41
- Bought
- $314K
- Sold
- $4.3M
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 13 Oct 2006
- Last trade
- 21 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 26 May 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 10 Oct 2025filed 15 Oct 2025 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,200 at $0.00 | filing |
| 10 Oct 2025filed 15 Oct 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $31K2,200 at $14.08 | filing |
| 10 Oct 2025filed 15 Oct 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $193K2,200 at $87.54 | filing |
| 10 Sep 2025filed 11 Sep 2025 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,200 at $0.00 | filing |
| 10 Sep 2025filed 11 Sep 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $31K2,200 at $14.08 | filing |
| 10 Sep 2025filed 11 Sep 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $159K2,200 at $72.45 | filing |
| 11 Aug 2025filed 12 Aug 2025 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,200 at $0.00 | filing |
| 11 Aug 2025filed 12 Aug 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $31K2,200 at $14.08 | filing |
| 11 Aug 2025filed 12 Aug 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $159K2,200 at $72.30 | filing |
| 10 Jul 2025filed 14 Jul 2025 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,200 at $0.00 | filing |
| 10 Jul 2025filed 14 Jul 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $31K2,200 at $14.08 | filing |
| 10 Jul 2025filed 14 Jul 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $156K2,200 at $71.08 | filing |
| 10 Jun 2025filed 12 Jun 2025 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,200 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $31K2,200 at $14.08 | filing |
| 10 Jun 2025filed 12 Jun 2025 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $155K2,200 at $70.61 | filing |
| 3 Jun 2025filed 4 Jun 2025 | CERS CerusMedical Devices | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 12 May 2025filed 14 May 2025 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,800 at $0.00 | filing |
News
TransMedics Group (NASDAQ:TMDX) and Cerus (NASDAQ:CERS) Head-To-Head ContrastCERS · themarketsdaily.com · 13 Oct 2026Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells $93,474.00 in StockCORT · tickerreport.com · 8 Oct 2026Comparing Corcept Therapeutics (NASDAQ:CORT) & Xeris Biopharma (NASDAQ:XERS)CORT · dailypolitical.com · 7 Oct 2026Corcept Therapeutics (NASDAQ:CORT) Stock: Insider Joseph Douglas Lyon Sells 9,190 SharesCORT · dailypolitical.com · 6 Oct 2026
0 headlines in the last 90 days name Daniel N. Swisher Jr.; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.